Literature DB >> 32721846

Diabetes, and its treatment, as an effector of autonomic nervous system circuits and its functions.

Liliana Espinoza1, Carie R Boychuk2.   

Abstract

Diabetes increases the risk of cardiovascular complications, including heart failure, hypertension, and stroke. There is a strong involvement of autonomic dysfunction in individuals with diabetes that exhibit clinical manifestations of cardiovascular diseases (CVD). Still, the mechanisms by which diabetes and its treatments alter autonomic function and subsequently affect cardiovascular complications remain elusive. For this reason, understanding the brainstem circuits involved in sensing metabolic state(s) and enacting autonomic control of the cardiovascular system are important to develop more comprehensive therapies for individuals with diabetes at increased risk for CVD. We review how autonomic nervous system circuits change during these disease states and discuss their potential role in current pharmacotherapies that target diabetic states. Overall, this review proposes that the brainstem circuits provide an integrative sensorimotor network capable of responding to metabolic cues to regulate cardiovascular function and this network is modified by, and in turn affects, diabetes-induced CVD and its treatment.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Year:  2020        PMID: 32721846     DOI: 10.1016/j.coph.2020.06.006

Source DB:  PubMed          Journal:  Curr Opin Pharmacol        ISSN: 1471-4892            Impact factor:   5.547


  2 in total

1.  Editorial: Cardiovascular and renal 2020: Cardiovascular protection by antidiabetic drugs: Key mechanisms and current clinical data.

Authors:  Matthew W Gorr; Loren E Wold
Journal:  Curr Opin Pharmacol       Date:  2020-10       Impact factor: 5.547

Review 2.  Targeting autonomic nervous system as a biomarker of well-ageing in the prevention of stroke.

Authors:  Jean-Claude Barthelemy; Vincent Pichot; David Hupin; Mathieu Berger; Sébastien Celle; Lytissia Mouhli; Magnus Bäck; Jean-René Lacour; Frederic Roche
Journal:  Front Aging Neurosci       Date:  2022-09-15       Impact factor: 5.702

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.